Answers are grounded in this paper and cite their sources.
In Europe, the 2007-08 winter season was dominated by infl uenza virus A (H1N1) circulation through week 7, followed by infl uenza B virus from week 8 onward. Oseltamivir-resistant infl uenza viruses A (H1N1) (ORVs) with H275Y mutation in the neuraminidase emerged independently of drug use. By country, the proportion of ORVs ranged from 0% to 68%, with the highest proportion in Norway. The average weighted prevalence of ORVs across Europe increased gradually over time, from near 0 in week 40 of 2007 to 56% in week 19 of 2008 (mean 20%). Neuraminidase genes of ORVs possessing the H275Y substitution formed a homogeneous subgroup closely related to, but distinguishable from, those of oseltamivir-sensitive infl uenza viruses A (H1N1). Minor variants of ORVs emerged independently, indicating multiclonal ORVs. Overall, the clinical effect of ORVs in Europe, measured by infl uenza-like illness or acute respiratory infection, was unremarkable and consistent with normal seasonal activity.
No takes yet. Share an insight, caveat, or question.
Meijer et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: